Please enable JavaScript to continue using this application.

Compare $TSHA vs $XNCR | Chartloom

Compare

$TSHA vs $XNCR

Taysha Gene Therapies Inc · Xencor Inc

TSHA

Taysha Gene Therapies Inc

XNCR

Xencor Inc

Compare $TSHA vs $XNCR

Comparing Taysha Gene Therapies Inc and Xencor Inc

TSHATaysha Gene Therapies Inc

XNCRXencor Inc

TSHATaysha Gene Therapies Inc

Market cap

$1.44B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

664.56x

Rev growth (TTM)

-32.3%

YTD performance

-14.5%

52W performance

-11.3%

FCF yield

-9.2%

XNCRXencor Inc

Market cap

$1.83B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.26x

Rev growth (TTM)

-33.2%

YTD performance

65.1%

52W performance

98.6%

FCF yield

-11.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TSHA

XNCR

Detailed metrics comparison

TSHA

Taysha Gene Therapies Inc

XNCR

Xencor Inc

Market Cap

TSHA$1.44B

XNCR$1.83B

Enterprise Value

TSHA$1.03B

XNCR$1.89B

Price

TSHA$4.49

XNCR$24.63

P/E Ratio

TSHAN/A

XNCRN/A

P/S Ratio

TSHA261.77x

XNCR17.40x

EV/Sales

TSHA187.75x

XNCR17.97x

EV/EBITDA

TSHA0.00x

XNCR31.73x

P/B Ratio

TSHA3.90x

XNCR3.71x

P/FCF Ratio

TSHAN/A

XNCRN/A

EV/FCF

TSHA-7.77x

XNCR-9.06x

PEG Ratio

TSHAN/A

XNCRN/A

Forward P/E (NTM)

TSHAN/A

XNCRN/A

Forward P/S (NTM)

TSHA664.56x

XNCR14.26x

Revenue (TTM)

TSHA$5M

XNCR$105M

Revenue Growth (YoY)

TSHA-32.3%

XNCR-33.2%

Forward Rev Growth

TSHA1272.3%

XNCR7.4%

Gross Margin (TTM)

TSHA0.0%

XNCR0.0%

Operating Margin (TTM)

TSHA0.0%

XNCR0.0%

EBITDA Margin (TTM)

TSHA-2833.6%

XNCR-188.5%

Net Margin (TTM)

TSHA-2728.0%

XNCR-155.6%

FCF Margin (TTM)

TSHA-2417.0%

XNCR-198.4%

Net Income (TTM)

TSHA$-150M

XNCR$-163M

FCF (TTM)

TSHA$-133M

XNCR$-208M

EPS (TTM)

TSHA-$0.41

XNCR-$2.15

ROE (TTM)

TSHA-5619.0%

XNCR-2866.0%

ROA (TTM)

TSHA-4184.0%

XNCR-2038.0%

ROIC (TTM)

TSHA-4729.0%

XNCR-2379.0%

Cash

TSHA$455M

XNCR$45M

Debt

TSHA$49M

XNCR$105M

Net Cash/Debt

TSHA$406M

XNCR$-60M

Current Ratio (TTM)

TSHA17.76x

XNCR6.39x

Quick Ratio (TTM)

TSHA17.57x

XNCR6.09x

Debt/Equity (TTM)

TSHA0.13x

XNCR0.21x

Debt/Assets (TTM)

TSHA0.0%

XNCR0.0%

Interest Coverage (TTM)

TSHAN/A

XNCRN/A

Net Debt/EBITDA (TTM)

TSHA0.00x

XNCR0.00x

Beta

TSHA1.37

XNCR0.81

52W Performance

TSHA-11.3%

XNCR98.6%

YTD Performance

TSHA-14.5%

XNCR65.1%

% from 52W High

TSHA-38.5%

XNCR-19.5%

% from 52W Low

TSHA21.6%

XNCR137.4%

Asset Turnover (TTM)

TSHA0.04x

XNCR0.13x

FCF Yield (TTM)

TSHA-9.2%

XNCR-11.4%

Earnings Yield (TTM)

TSHA-10.4%

XNCR-8.9%

Dividend Yield (TTM)

TSHAN/A

XNCRN/A

Rule of 40

TSHA-2,449.3

XNCR-231.6

EV/GP/RG

TSHAN/A

XNCRN/A

Ticker research

View TSHA research View XNCR research

Metric	TSHA Taysha Gene Therapies Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.44B	$1.83B
Enterprise Value	$1.03B	$1.89B
Price	$4.49	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	261.77x	17.40x
EV/Sales	187.75x	17.97x
EV/EBITDA	0.00x	31.73x
P/B Ratio	3.90x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.77x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	664.56x	14.26x
Revenue & Growth
Revenue (TTM)	$5M	$105M
Revenue Growth (YoY)	-32.3%	-33.2%
Forward Rev Growth	1272.3%	7.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2833.6%	-188.5%
Net Margin (TTM)	-2728.0%	-155.6%
FCF Margin (TTM)	-2417.0%	-198.4%
Net Income (TTM)	$-150M	$-163M
FCF (TTM)	$-133M	$-208M
EPS (TTM)	-$0.41	-$2.15
ROE (TTM)	-5619.0%	-2866.0%
ROA (TTM)	-4184.0%	-2038.0%
ROIC (TTM)	-4729.0%	-2379.0%
Financial Health
Cash	$455M	$45M
Debt	$49M	$105M
Net Cash/Debt	$406M	$-60M
Current Ratio (TTM)	17.76x	6.39x
Quick Ratio (TTM)	17.57x	6.09x
Debt/Equity (TTM)	0.13x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.81
52W Performance	-11.3%	98.6%
YTD Performance	-14.5%	65.1%
% from 52W High	-38.5%	-19.5%
% from 52W Low	21.6%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.13x
FCF Yield (TTM)	-9.2%	-11.4%
Earnings Yield (TTM)	-10.4%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,449.3	-231.6
EV/GP/RG	N/A	N/A
Ticker research	View TSHA research	View XNCR research

Valuation

P/S Ratio

XNCR

17.40x

TSHA

261.77x

EV/FCF

XNCR

-9.06x

TSHA

-7.77x

Growth & revenue

Revenue Growth TTM

TSHA

-32.3%

XNCR

-33.2%

Forward Revenue Growth

TSHA

1272.3%

XNCR

7.4%

Profitability & performance

Gross Margin

TSHA

0.0%

XNCR

0.0%

ROE

XNCR

-2866.0%

TSHA

-5619.0%

FCF Yield %

TSHA

-9.2%

XNCR

-11.4%

52-Week Performance

XNCR

98.6%

TSHA

-11.3%

Detailed metrics comparison

TSHA

Taysha Gene Therapies Inc

XNCR

Xencor Inc

Market Cap

TSHA$1.44B

XNCR$1.83B

Enterprise Value

TSHA$1.03B

XNCR$1.89B

Price

TSHA$4.49

XNCR$24.63

P/E Ratio

TSHAN/A

XNCRN/A

P/S Ratio

TSHA261.77x

XNCR17.40x

EV/Sales

TSHA187.75x

XNCR17.97x

EV/EBITDA

TSHA0.00x

XNCR31.73x

P/B Ratio

TSHA3.90x

XNCR3.71x

P/FCF Ratio

TSHAN/A

XNCRN/A

EV/FCF

TSHA-7.77x

XNCR-9.06x

PEG Ratio

TSHAN/A

XNCRN/A

Forward P/E (NTM)

TSHAN/A

XNCRN/A

Forward P/S (NTM)

TSHA664.56x

XNCR14.26x

Revenue (TTM)

TSHA$5M

XNCR$105M

Revenue Growth (YoY)

TSHA-32.3%

XNCR-33.2%

Forward Rev Growth

TSHA1272.3%

XNCR7.4%

Gross Margin (TTM)

TSHA0.0%

XNCR0.0%

Operating Margin (TTM)

TSHA0.0%

XNCR0.0%

EBITDA Margin (TTM)

TSHA-2833.6%

XNCR-188.5%

Net Margin (TTM)

TSHA-2728.0%

XNCR-155.6%

FCF Margin (TTM)

TSHA-2417.0%

XNCR-198.4%

Net Income (TTM)

TSHA$-150M

XNCR$-163M

FCF (TTM)

TSHA$-133M

XNCR$-208M

EPS (TTM)

TSHA-$0.41

XNCR-$2.15

ROE (TTM)

TSHA-5619.0%

XNCR-2866.0%

ROA (TTM)

TSHA-4184.0%

XNCR-2038.0%

ROIC (TTM)

TSHA-4729.0%

XNCR-2379.0%

Cash

TSHA$455M

XNCR$45M

Debt

TSHA$49M

XNCR$105M

Net Cash/Debt

TSHA$406M

XNCR$-60M

Current Ratio (TTM)

TSHA17.76x

XNCR6.39x

Quick Ratio (TTM)

TSHA17.57x

XNCR6.09x

Debt/Equity (TTM)

TSHA0.13x

XNCR0.21x

Debt/Assets (TTM)

TSHA0.0%

XNCR0.0%

Interest Coverage (TTM)

TSHAN/A

XNCRN/A

Net Debt/EBITDA (TTM)

TSHA0.00x

XNCR0.00x

Beta

TSHA1.37

XNCR0.81

52W Performance

TSHA-11.3%

XNCR98.6%

YTD Performance

TSHA-14.5%

XNCR65.1%

% from 52W High

TSHA-38.5%

XNCR-19.5%

% from 52W Low

TSHA21.6%

XNCR137.4%

Asset Turnover (TTM)

TSHA0.04x

XNCR0.13x

FCF Yield (TTM)

TSHA-9.2%

XNCR-11.4%

Earnings Yield (TTM)

TSHA-10.4%

XNCR-8.9%

Dividend Yield (TTM)

TSHAN/A

XNCRN/A

Rule of 40

TSHA-2,449.3

XNCR-231.6

EV/GP/RG

TSHAN/A

XNCRN/A

Ticker research

View TSHA research View XNCR research

Metric	TSHA Taysha Gene Therapies Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.44B	$1.83B
Enterprise Value	$1.03B	$1.89B
Price	$4.49	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	261.77x	17.40x
EV/Sales	187.75x	17.97x
EV/EBITDA	0.00x	31.73x
P/B Ratio	3.90x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.77x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	664.56x	14.26x
Revenue & Growth
Revenue (TTM)	$5M	$105M
Revenue Growth (YoY)	-32.3%	-33.2%
Forward Rev Growth	1272.3%	7.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2833.6%	-188.5%
Net Margin (TTM)	-2728.0%	-155.6%
FCF Margin (TTM)	-2417.0%	-198.4%
Net Income (TTM)	$-150M	$-163M
FCF (TTM)	$-133M	$-208M
EPS (TTM)	-$0.41	-$2.15
ROE (TTM)	-5619.0%	-2866.0%
ROA (TTM)	-4184.0%	-2038.0%
ROIC (TTM)	-4729.0%	-2379.0%
Financial Health
Cash	$455M	$45M
Debt	$49M	$105M
Net Cash/Debt	$406M	$-60M
Current Ratio (TTM)	17.76x	6.39x
Quick Ratio (TTM)	17.57x	6.09x
Debt/Equity (TTM)	0.13x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.81
52W Performance	-11.3%	98.6%
YTD Performance	-14.5%	65.1%
% from 52W High	-38.5%	-19.5%
% from 52W Low	21.6%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.13x
FCF Yield (TTM)	-9.2%	-11.4%
Earnings Yield (TTM)	-10.4%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,449.3	-231.6
EV/GP/RG	N/A	N/A
Ticker research	View TSHA research	View XNCR research